Hasnain Faheem
Reporting owner on Forms 3, 4 and 5, CIK 1352620.
Hasnain Faheem reported on 1 issuer in 3 filings, the latest a Form 4 filed 2026-11-09.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ASPE · Aspen Neuroscience, Inc.CIK 2124080 | director, officer (Executive Chair) | 3 | 2026-11-09 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ASPE · Aspen Neuroscience, Inc.Common Stock | 2026-11-05 | A granted | +321,672 | $0 | 348,330 | Form 4 |
| ASPE · Aspen Neuroscience, Inc.Common Stock, holding | 36,349 | Form 4 | ||||
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | C converted | +14,913 | 14,913 | Form 4 | |
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | C converted | +14,316 | 14,316 | Form 4 | |
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | C converted | +7,120 | 7,120 | Form 4 | |
| Aspen Neuroscience, Inc. Common Stock, holding | 26,658 | Form 4 | ||||
| Aspen Neuroscience, Inc. Series A-1 Convertible Preferred Stock, derivative | 2026-11-02 | C converted | -14,913 | 0 | Form 4 | |
| Aspen Neuroscience, Inc. Series A-2 Convertible Preferred Stock, derivative | 2026-11-02 | C converted | -14,316 | 0 | Form 4 | |
| Aspen Neuroscience, Inc. Series C Convertible Preferred Stock, derivative | 2026-11-02 | C converted | -7,120 | 0 | Form 4 | |
| Aspen Neuroscience, Inc. Common Stock, holding | 26,658 | Form 3 | ||||
| Aspen Neuroscience, Inc. Series A-1 Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Aspen Neuroscience, Inc. Series A-2 Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Aspen Neuroscience, Inc. Series C Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Aspen Neuroscience, Inc. Stock Option (Right to Buy), derivative, holding | Form 3 | |||||
| Aspen Neuroscience, Inc. Stock Option (Right to Buy), derivative, holding | Form 3 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-453834 | Aspen Neuroscience, Inc. | 2026-11-09 | ||
| Form 4 0001193125-26-444126 | Aspen Neuroscience, Inc. | 2026-11-02 | ||
| Form 3 0001193125-26-439140 | Aspen Neuroscience, Inc. | 2026-10-29 |